Histatin 3-mediated killing of Candida albicans: Effect of extracellular salt concentration on binding and internalization

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 9, 1999, Pages 2256-2262

  Xu, Yanying ^a,e   Ambudkar, Indu ^a   Yamagishi, Hisako ^a,f   Swaim, William ^b   Walsh, Thomas J ^c   O'Connell, Brian C ^a,d  

^a Gene Therapy and Therapeutics Branch   (United States)

^b Biological Imaging Core   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^d TRINITY COLLEGE DUBLIN   (Ireland)

^e PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^f TOKYO DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTATIN; INORGANIC SALT;

ARTICLE; BINDING KINETICS; CANDIDA ALBICANS; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BINDING; DRUG MECHANISM; DRUG PENETRATION; FUNGICIDAL ACTIVITY; NONHUMAN; PRIORITY JOURNAL; SALIVA; TEMPERATURE SENSITIVITY;

EID: 0032825193     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.9.2256     Document Type: Article

References (31)

1. Azen, E. A., W. Leutenegger, and E. H. Peters. 1978. Evolutionary and dietary aspects of salivary basic (Pb) and post Pb (PPb) proteins in anthropod primates. Nature 273:775-778.
2. Balekjian, A. Y., and R. W. Longton. 1973. Histones isolated from human parotid fluid. Biochem. Biophys. Res. Commun. 50:676-682.
3. Brant, E. C., R. P. Santarpia, and J. J. Pollock. 1990. Role of pH in salivary histidine-rich polypeptide antifungal germ tube inhibitory activity. Oral Microbiol. Immunol. 5:336-339.
4. Dawes, C. 1974. The effects of flow rate and duration of stimulation on the concentrations of protein and the main electrolytes in human submandibular saliva. Arch. Oral Biol. 19:887-895.
5. De Lucca, A. J., and T. J. Walsh. 1999. Antifungal peptides: novel therapeutic compounds against emerging pathogens. Antimicrob. Agents Chemother. 43:1-11.
6. Driscoll, J., C. Duan, Y. Zuo, T. Xu, R. Troxler, and F. G. Oppenheim. 1996. Candidacidal activity of human salivary histatin recombinant variants produced by site-directed mutagenesis. Gene 177:29-34.
7. Edgerton, M., S. E. Koshlukova, T. E. Lo, B. G. Chrzan, R. M. Straubinger, and P. A. Raj. 1998. Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans. J. Biol. Chem. 273: 20438-20447.
8. Hay, D. I. 1975. Fractionation of human parotid salivary proteins and the isolation of an histidine-rich acidic peptide which shows high affinity for hydroxyapatite surfaces. Arch. Oral Biol. 20:553-558.
9. Helmerhorst, E. J., P. Breeuwer, W. van't Hof, E. Walgreen-Weterings, L. C. Oomen, E. C. Veerman, A. V. Amerongen, and T. Abee. 1999. The cellular target of histatin 5 on Candida albicans is the energized mitochondrion. J. Biol. Chem. 274:7286-7291.
10. Helmerhorst, E. J., I. M. Reijnders, W. V. Hof, I. Simoons-Smit, E. C. Veerman, and A. V. Amerongen. 1999. Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides. Antimicrob. Agents Chemother. 43:702-704.
11. Helmerhorst, E. J., W. Van't Hof, E. C. Veerman, I. Simoons-Smit, and A. V. Nieuw Amerongen. 1997. Synthetic histatin analogues with broad-spectrum antimicrobial activity. Biochem. J. 326:39-45.
12. Jentoft, N., and D. G. Dearborn. 1979. Labeling of proteins by reductive methylation using sodium cyanoborohydride. J. Biol. Chem. 254:4359-4365.
13. Kato, T., N. Takahashi, and H. K. Kuramitsu. 1992. Sequence analysis and characterization of the Porphyromonas gingivalis prtC gene, which expresses a novel collagenase activity. J. Bacteriol. 174:3889-3895.
14. MacKay, B. J., L. Denepitiya, V. J. Iacono, S. B. Krost, and J. J. Pollock. 1984. Growth-inhibitory and bactericidal effects of human parotid salivary histidine-rich polypeptides on Streptococcus mutans. Infect. Immun. 44:695-701.
15. Murakami, Y., H. Nagata, A. Amano, M. Takagaki, S. Shizukuishi, A. Tsunemitsu, and S. Aimoto. 1991. Inhibitory effects of human salivary histatins and lysozyme on coaggregation between Porphyromonas gingivalis and Streptococcus mitis. Infect. Immun. 59:3284-3286.
16. Murakami, Y., H. Nagata, S. Shizukuishi, K. Nakashima, T. Okawa, M. Takigawa, and A. Tsunemitsu. 1994. Histatin as a synergistic stimulator with epidermal growth factor of rabbit chondrocyte proliferation. Biochem. Biophys. Res. Commun. 198:274-280.
17. Murakami, Y., S. Shizukuishi, A. Tsunemitsu, K. Nakashima, Y. Kato, and S. Aimoto. 1991. Binding of a histidine-rich peptide to Porphyromonas gingivalis. FEMS Microbiol. Lett. 66:253-256.
18. Nishikata, M., T. Kanehira, H. Oh, H. Tani, M. Tazaki, and Y. Kuboki. 1991. Salivary histatin as an inhibitor of a protease produced by the oral bacterium Bacteroides gingivalis. Biochem. Biophys. Res. Commun. 174:625-630.
19. Oppenheim, F. G., Y. C. Yang, R. D. Diamond, D. Hyslop, G. D. Offner, and R. F. Troxler. 1986. The primary structure and functional characterization of the neutral histidine-rich polypeptide from human parotid secretion. J. Biol. Chem. 261:1177-1182.
20. Pollock, J. J., L. Denepitiya, B. J. MacKay, and V. J. Iacono. 1984. Fungi-static and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans. Infect. Immun. 44:702-707.
21. Raj, P. A., M. Edgerton, and M. J. Levine. 1990. Salivary histatin 5: dependence of sequence, chain length, and helical conformation for candidacidal activity. J. Biol. Chem. 265:3898-3905.
22. Raj, P. A., E. Marcus, and D. K. Sukumaran. 1998. Structure of human salivary histatin 5 in aqueous and nonaqueous solutions. Biopolymers 45:51-67.
23. Raj, P. A., S. D. Soni, and M. J. Levine. 1994. Membrane-induced helical conformation of an active candidacidal fragment of salivary histatins. J. Biol. Chem. 269:9610-9619.
24. Ramalingam, K., T. L. Gururaja, N. Ramasubbu, and M. J. Levine. 1996. Stabilization of helix by side-chain interactions in histatin-derived peptides: role in candidacidal activity. Biochem. Biophys. Res. Commun. 225:47-53.
25. Rayhan, R., L. Xu, R P. Santarpia, C. A. Tylenda, and J. J. Pollock. 1992. Antifungal activities of salivary histidine-rich polypeptides against Candida albicans and other oral yeast isolates. Oral Microbiol. Immunol. 7:51-52.
26. Santarpia, R. P., M. I. Cho, and J. J. Pollock. 1990. Parameters affecting the inhibition of Candida albicans GDH 2023 and GRI 2773 blastospore viability by purified synthetic salivary histidine-rich polypeptides. Oral Microbiol. Immunol. 5:226-232.
27. Sugiyama, K., Y. Suzuki, and H. Furuta. 1985. Isolation and characterization of histamine-releasing peptides from human parotid saliva. Life Sci. 37:475-480.
28. Tsai, H., and L. A. Bobek. 1997. Studies of the mechanism of human salivary histatin-5 candidacidal activity with histatin-5 variants and azole-sensitive and -resistant Candida species. Antimicrob. Agents Chemother. 41:2224-2228.
29. Walsh, T. J., S. Aokl, F. Mechinaud, J. Bacher, J. Lee, M. Rubin, and P. A. Pizzo. 1990. Effects of preventive, early, and late antifungal chemotherapy with fiuconazole in different granulocytopenic models of experimental disseminated candidiasis. J. Infect. Dis. 161:755-760.
30. Xu, L., K. Lal, R. P. Santarpia, and J. J. Pollock. 1993. Salivary proteolysis of histidine-rich polypeptides and the antifungal activity of peptide degradation products. Arch. Oral Biol. 38:277-283.
31. Xu, T., S. M. Levitz, R. D. Diamond, and F. G. Oppenheim. 1991. Anticandidal activity of major human salivary histatins. Infect. Immun. 59:2549-2554.